Compounds > cyclo(alanine-(1-amino-1-cyclopentane)carbonyl)
Page last updated: 2024-09-03

cyclo(alanine-(1-amino-1-cyclopentane)carbonyl) and Nerve Degeneration

cyclo(alanine-(1-amino-1-cyclopentane)carbonyl) has been researched along with Nerve Degeneration in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Keilhoff, G; Stastný, F; Wolf, G1

Other Studies

1 other study(ies) available for cyclo(alanine-(1-amino-1-cyclopentane)carbonyl) and Nerve Degeneration

ArticleYear
Effects of MK-801, ketamine and alaptide on quinolinate models in the maturing hippocampus.
    Neuroscience, 1991, Volume: 42, Issue:2

    Topics: Animals; Cell Hypoxia; Dizocilpine Maleate; Hippocampus; Injections, Intraventricular; Ketamine; Male; Nerve Degeneration; Neuropeptides; Peptides, Cyclic; Quinolinic Acid; Quinolinic Acids; Rats; Rats, Inbred Strains

1991